Telix Pharmaceuticals Limited ( TLPPF) - Key Metrics
TLPPF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $1.86 | -$0.02 | -$0.16 | -$0.28 |
| 2025Q2 | $1.76 | -$0.01 | $0.08 | $0.05 |
| 2024Q4 | $1.79 | $0.12 | $0.03 | -$0.03 |
| 2024Q2 | $0.57 | $0.03 | $0.10 | $0.06 |
| 2023Q4 | $0.87 | $0.06 | $0.03 | $0.01 |
TLPPF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -128.61 |
| 2025Q2 | ? | -591.15 |
| 2024Q4 | ? | 53.29 |
| 2024Q2 | ? | 129.41 |
| 2023Q4 | ? | 41.77 |
TLPPF
Price: $10.48
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -350
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.2 billion